Format

Send to

Choose Destination
Eur J Cancer Prev. 2007 Dec;16(6):564-7.

The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.

Author information

1
Clinical and Descriptive Epidemiology Unit, Centre for the Study and Prevention of Cancer, Scientific Institute of the Tuscan Region, Florence, Italy. e.crocetti@cspo.it

Abstract

To evaluate the effectiveness of a cytological screening to prevent invasive cervical cancer in the province of Trento, a northern Italian area where a population-based cancer registry is active. The history of Pap test was evaluated through a case-control study in 61 population-based invasive cervical cancer patients, incident during 1995-2000, and in 244 age-matched (between 25 and 75 years old) controls. Women who had at least one Pap test had a reduced risk of invasive carcinoma of 80% (odds ratio=0.20; 95% confidence intervals 0.10-0.40). The protection of a previous Pap test for both squamous cell carcinoma (odds ratio=0.23; 95% confidence intervals 0.09-0.58) and adenocarcinoma (odds ratio=0.24; 95% confidence intervals 0.07-0.78) was similar. The overall protective effect of the Pap test was not seen among younger women (<40 years). The protective effect of the Pap test seems to be stronger for shorter intervals. Our study confirms that Pap-test screening, particularly in middle-aged and older women, is an effective public health intervention with encouraging results also for the prevention of cervical adenocarcinoma.

PMID:
18090131
DOI:
10.1097/CEJ.0b013e3280145c14
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center